DNMT3A and metastatic malignant neoplasm in the lymph nodes: Results: Low expression of DNMT3A (p = 0.045) and the presence of locoregional lymph node metastases at diagnosis (N+-status) (p = 0.002) were associated with disease-specific mortality.